Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial.

CNS Drugs · 2026 · PMC12769605 · PMID 40932600

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginally significantP = 0.06so close (0.05 < p ≤ 0.1)

Both tests showed, however, a marginally significant fit ( P = 0.06), most probably due to a low statistical power of the subsample and a resulting higher type II error.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.